Cooley-Led Biotech Firm Leads 4 IPOs Totaling $847M
Cancer-focused Lyell Immunopharma Inc. went public Thursday after raising $425 million, the largest of four IPOs totaling $847 million that also included a gene-editing biotechnology firm, an online marketplace for biospecimens...To view the full article, register now.
Already a subscriber? Click here to view full article